Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
By L. Mosca, Emelia J. Benjamin, K. Berra, J. Bezanson, R. Dolor, D. M. Lloyd-Jones, L. Newby, Ileana L. Piña, Véronique L. Roger, Leslee J. Shaw and 27 more. Journal of the American College of Cardiology, 2011
1,773 citations recorded by the source corpus.
Substantial progress has been made in the awareness, treatment, and prevention of cardiovascular disease (CVD) in women since the first women-specific clinical recommendations for the prevention of CVD were published by the American Heart Association (AHA) in 1999.1 The myth that heart disease is a “man's disease” has been debunked; the rate of public awareness of CVD as the leading cause of death among US women has increased from 30% in 1997 to 54% in 2009.2 The age-adjusted death rate resulting from coronary heart disease (CHD) in females, which accounts for about half of all CVD deaths in women, was 95.7 per 100 000 females in 2007, a third of what it was in 1980.3,4 Approximately 50% of this decline in CHD deaths has been attributed to reducing major risk factors and the other half to treatment of CHD including secondary preventive therapies.4 Major randomized controlled clinical trials such as the Women's Health Initiative have changed the practice of CVD prevention in women over the past decade.5 The investment in combating this major public health issue for women has been significant, as have the scientific and medical achievements. Despite the gains that have been made, considerable challenges remain. In 2007, CVD still caused ≈1 death per minute among women in the United States.6 These represent 421 918 deaths, more women's lives than were claimed by cancer, chronic lower respiratory disease, Alzheimer disease, and accidents combined.6 Reversing a trend of the past 4 decades, CHD death rates in US women 35 to 54 years of age now actually appear to be increasing, likely because of the effects of the obesity epidemic.4 CVD rates in the United States are significantly higher for black females compared with their white counterparts (286.1/100 000 versus …
Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/e5cfed8982b4399bcf9d7bb9931d3204f4424a3c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Cardiovascular disease in women (2010, neutral): “Physician referral patterns, program structure, and patient preferences influence the degree of CR participation among women.(122,200) Recommendations to attend CR programs need to be consistently offered to all women and reinforced by all health staff, including physicians.”
- Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016, methodology): “without B 6 and B 12 , should not be used for secondary prevention after MI because there is no evidence of benefit.(57,216,217)”
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, neutral): “The cardiologist also helps the patient comply with the recommendations, by providing them with written information and ensuring that, at given intervals, treatment goals are reached.(82,552) This approach has a significant impact on mid-term prognosis.”
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. (2016, background): “26 Answer: Women diagnosed with HDP should be approached for screening with a lipid panel regardless of age.”
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “Hypertensive disorders have been recognized as an important risk factor for CVD in women.(495) Therefore lifestyle modifications and regular check-ups of BPand metabolic factors are recommended after delivery, to reduce future CVD.”